ATE232910T1 - Syntheseverfahren für inhibitoren der hmg-coa- reduktase - Google Patents

Syntheseverfahren für inhibitoren der hmg-coa- reduktase

Info

Publication number
ATE232910T1
ATE232910T1 AT94917312T AT94917312T ATE232910T1 AT E232910 T1 ATE232910 T1 AT E232910T1 AT 94917312 T AT94917312 T AT 94917312T AT 94917312 T AT94917312 T AT 94917312T AT E232910 T1 ATE232910 T1 AT E232910T1
Authority
AT
Austria
Prior art keywords
hmg
coa reductase
inhibitors
synthesis method
reductase inhibitors
Prior art date
Application number
AT94917312T
Other languages
English (en)
Inventor
Giorgio Carta
Michael J Conder
John Lloyd Gainer
Robert W Stieberg
Victor A Vinci
Timothy Wallace Weber
Original Assignee
Merck & Co Inc
Univ Virginia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc, Univ Virginia filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE232910T1 publication Critical patent/ATE232910T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/921Candida

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AT94917312T 1993-05-11 1994-05-06 Syntheseverfahren für inhibitoren der hmg-coa- reduktase ATE232910T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/060,847 US5420024A (en) 1993-05-11 1993-05-11 Process for synthesis of acylated HMG-CoA reductase inhibitors from a lactone diol precursor using Candida cylindracea
PCT/US1994/005019 WO1994026920A1 (en) 1993-05-11 1994-05-06 PROCESS FOR SYNTHESIS OF HMG-CoA REDUCTASE INHIBITORS

Publications (1)

Publication Number Publication Date
ATE232910T1 true ATE232910T1 (de) 2003-03-15

Family

ID=22032112

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94917312T ATE232910T1 (de) 1993-05-11 1994-05-06 Syntheseverfahren für inhibitoren der hmg-coa- reduktase

Country Status (10)

Country Link
US (1) US5420024A (de)
EP (1) EP0698111B1 (de)
JP (1) JPH08510128A (de)
AT (1) ATE232910T1 (de)
AU (1) AU673268B2 (de)
CA (1) CA2161788C (de)
DE (1) DE69432144T2 (de)
DK (1) DK0698111T3 (de)
ES (1) ES2190441T3 (de)
WO (1) WO1994026920A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI20072A (sl) * 1998-09-18 2000-04-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze
US7141602B2 (en) * 1998-09-18 2006-11-28 Lek Pharmaceuticals D.D. Process for obtaining HMG-CoA reductase inhibitors of high purity
WO2001030773A2 (en) 1999-10-27 2001-05-03 Merck & Co., Inc. Lactonization process
CN102703539A (zh) * 2003-10-21 2012-10-03 维莱尼姆公司 制备新伐他汀及中间体的方法
US20110059493A1 (en) * 2007-08-27 2011-03-10 Brian Morgan Methods for Making Simvastatin and Intermediates
CN102574896B (zh) 2009-09-30 2015-04-08 科德克希思公司 变异LovD多肽及其用途
CN102695792B (zh) 2009-10-08 2015-02-18 加利福尼亚大学董事会 对辛伐他汀合成表现出改善性质的LovD突变体
KR102051508B1 (ko) * 2018-07-23 2019-12-03 중앙대학교 산학협력단 프로피오닐 에스테르 유도체를 유효성분으로 함유하는 x-연관 부신백질이영양증 예방 또는 치료용 약학조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60176595A (ja) * 1984-02-21 1985-09-10 Akira Endo 生理活性物質ml−236a及びモナコリンjの製造法
US5223415A (en) * 1990-10-15 1993-06-29 Merck & Co., Inc. Biosynthetic production of 7-[1',2',6',7',8',8a'(R)-hexahydro-2'(S),6'(R)-dimethyl-8'(S)-hydroxy-1'(S)-naphthyl]-3(R),5(R)-dihydroxyheptanoic acid (triol acid)
GB2255974A (en) * 1991-05-24 1992-11-25 Merck & Co Inc Enzymatic deacylation of simvastatin

Also Published As

Publication number Publication date
EP0698111A4 (de) 1998-08-26
AU6907294A (en) 1994-12-12
CA2161788C (en) 2001-10-16
US5420024A (en) 1995-05-30
EP0698111A1 (de) 1996-02-28
DK0698111T3 (da) 2003-03-31
AU673268B2 (en) 1996-10-31
ES2190441T3 (es) 2003-08-01
EP0698111B1 (de) 2003-02-19
DE69432144T2 (de) 2003-11-13
JPH08510128A (ja) 1996-10-29
WO1994026920A1 (en) 1994-11-24
CA2161788A1 (en) 1994-11-24
DE69432144D1 (de) 2003-03-27

Similar Documents

Publication Publication Date Title
ES2073529T3 (es) Inhibidor de fosfolipasa a2, microorganismos que producen este inhibidor y procedimiento para su produccion.
GEP19970948B (en) Method for Production of Imidazolidine
ATE232910T1 (de) Syntheseverfahren für inhibitoren der hmg-coa- reduktase
ES2061451T3 (es) Derivados de trans-6-(2-(n-heteroaril-3,5-disubstituido)pirazol-4-il)-etil)- o etenil)tetrahidro-4-hidroxipiran-2-ona, un proceso para su preparacion y uso de los mismos.
ATE296357T1 (de) Verfahren zur herstellung von hochreinen hmg-coa reductase inhibitoren
EP0605033B1 (de) Enzymatisches Verfahren zur stereoselektiven Herstellung einem Enantiomer aus einem hetero bicyclischen Alkohols
DK0649907T3 (da) Enzymatisk hydroxyleringsproces til fremstilling af HMG-CoA-reduktaseinhibitorer og mellemprodukter derfor
Horneman et al. Highly functionalized cyclopentanes by radical cyclization of unsaturated bromolactones. 2. A facile synthesis of the first carbaaldohexofuranoses and their conversion to carbapentofuranoses
CA1245226A (en) METHOD FOR THE PREPARATION OF HMG-COA REDUCTASE INHIBITORS AND INTERMEDIATE COMPOUNDS
EP1288213A4 (de) Verfahren für die herstellung von optisch aktiven 2-[6-(hydroxymethyl)-1,3-dioxan-4-yl]essigsäure-derivaten (19.12.01)
DE69908909D1 (de) Verfahren zur herstellung von simvastatin und ihren derivaten
EP0927755A3 (de) Haloacetoacetatreductase,Verfahren zur Herstellung und Verfahren zur Herstellung von Alcoholen damit
MURATA et al. Asymmetric synthesis of a chiral norbornene derivative by lipase-catalyzed transesterification of cis-endo-5-norbornene-2, 3-dimethanol and its application to the synthesis of an optically active TXA2 antagonist
NO306297B1 (no) FremgangsmÕte for fremstilling av HIV-proteaseinhibitorer
HUP9902113A2 (hu) Eljárás intermedierek előállítására gombaellenes szerek szintéziséhez
Rychnovsky et al. Enantioselective reduction of esters: synthesis of optically active α-acetoxy ethers
WO1987006266A1 (en) ENZYMATIC PROCESS FOR PREPARING OPTICALLY-ACTIVE 1,2-DIHYDRO-3H-PYRROLO[1,2a]PYRROLE-1-CARBOXYLIC ACID DERIVATIVES
DK0624568T3 (da) Forbedret fremgangsmåde til fremstilling af L-(-)-carnitin ud fra et affaldsprodukt med modsat konfiguration
Bertoli et al. Chemoenzymatic synthesis of optically active α-methylene-γ-carboxy-γ-lactams and γ-lactones
DE69823333D1 (de) Ein verbessertes Verfahren zur Herstellung von Statinen
Shimada et al. Efficient stereocontrol of a quaternary chiral center in the cyclohexene systems. Potential chiral synthons for vitamin D and related compounds by enzymatic approach
Salazar et al. Resolution of 3-α-naphthoxy-1, 2-propanediol using Candida antarctica lipase
WO2000052012A8 (en) A method for synthesizing porphyrin compounds
BR0013025A (pt) Processo para preparar ácidos via ésteres alfa-cloroepóxi
DE69629703D1 (de) Synthese von optisch reinen verbindungen als garft-inhibitoren und deren zwischenprodukte

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0698111

Country of ref document: EP

REN Ceased due to non-payment of the annual fee